Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment
- PMID: 36479105
- PMCID: PMC9721393
- DOI: 10.3389/fimmu.2022.1037124
Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment
Abstract
Human papillomaviruses (HPVs) have been recognized as the etiologic agents of various cancers and are called HPV-driven cancers. Concerning HPV-mediated carcinogenic action, gene therapy can cure cancer at the molecular level by means of the correction of specific genes or sites. CRISPR-Cas9, as a novel genetic editing technique, can correct errors in the genome and change the gene expression and function in cells efficiently, quickly, and with relative ease. Herein, we overviewed studies of CRISPR-mediated gene remedies for HPV-driven cancers and summarized the potential applications of CRISPR-Cas9 in gene therapy for cancer.
Keywords: cancer treatment; clustered regularly interspaced short palindromic repeat/CRISPR-associated nuclease 9; gene editing; human papillomavirus; tumor microenvironment.
Copyright © 2022 Wei, Zhao and Ma.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Research Status of Clustered Regulary Interspaced Short Palindromic Repeats Technology in the Treatment of Human Papillomavirus (HPV) Infection Related Diseases.Cancer Control. 2025 Jan-Dec;32:10732748241300654. doi: 10.1177/10732748241300654. Cancer Control. 2025. PMID: 39834176 Free PMC article. Review.
-
Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer.Cell Physiol Biochem. 2017;44(6):2455-2466. doi: 10.1159/000486168. Epub 2017 Dec 18. Cell Physiol Biochem. 2017. PMID: 29268281 Review.
-
Human Papillomavirus Oncogene Manipulation Using Clustered Regularly Interspersed Short Palindromic Repeats/Cas9 Delivered by pH-Sensitive Cationic Liposomes.Hum Gene Ther. 2020 Mar;31(5-6):309-324. doi: 10.1089/hum.2019.312. Epub 2020 Feb 19. Hum Gene Ther. 2020. PMID: 31973584
-
Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.Hum Gene Ther. 2020 Mar;31(5-6):297-308. doi: 10.1089/hum.2019.246. Hum Gene Ther. 2020. PMID: 31989837
-
CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice.PLoS One. 2021 Jan 7;16(1):e0223288. doi: 10.1371/journal.pone.0223288. eCollection 2021. PLoS One. 2021. PMID: 33411765 Free PMC article.
Cited by
-
Editorial: Complexity of tumor microenvironment: A major culprit in cancer development, volume II.Front Endocrinol (Lausanne). 2023 Jan 12;13:1126778. doi: 10.3389/fendo.2022.1126778. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36714569 Free PMC article. No abstract available.
-
The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer.Biomolecules. 2024 Jul 30;14(8):925. doi: 10.3390/biom14080925. Biomolecules. 2024. PMID: 39199313 Free PMC article. Review.
-
Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment.Vaccines (Basel). 2023 Aug 11;11(8):1354. doi: 10.3390/vaccines11081354. Vaccines (Basel). 2023. PMID: 37631922 Free PMC article. Review.
-
Genome Editing in Gynecological Oncology: The Emerging Role of CRISPR/Cas9 in Precision Cancer Therapy.Ther Innov Regul Sci. 2025 May 20. doi: 10.1007/s43441-025-00807-w. Online ahead of print. Ther Innov Regul Sci. 2025. PMID: 40394347 Review.
-
HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy.Virol J. 2025 May 22;22(1):156. doi: 10.1186/s12985-025-02783-x. Virol J. 2025. PMID: 40400023 Free PMC article. Review.
References
-
- Choi JH, Shin M, Yang L, Conley B, Yoon J, Lee SN, et al. . Clustered regularly interspaced short palindromic repeats-mediated amplification-free detection of viral DNAs using surface-enhanced raman spectroscopy-active nanoarray. ACS Nano (2021) 15: 13475–85. doi: 10.1021/acsnano.1c03975 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical